FDA Warns of Common Diabetes Meds ' , SGLT2 Inhibitors, Link to Dangerous Genital Infection
THURSDAY, Aug. 30, 2018 -- Rare but serious genital infections, as well as one death, have been reported in some patients taking a certain class of type 2 diabetes medicine, the U.S. Food and Drug Administration says.
As a result, the FDA has...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Food and Drug Administration (FDA) | General Medicine | SGLT2 Inhibitors